Strategic Global Advisors, LLC Teva Pharmaceutical Industries LTD Transaction History

Strategic Global Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$6.16 - $9.6 $540,305 - $842,035	-87,712 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$8.12 - $15.72 $4.35 Million - $8.42 Million	-535,388 Reduced 85.92%	87,712 $810,000
Q1 2019 May 13, 2019	BUY	$15.58 - $20.01 $163,652 - $210,185	10,504 Added 1.71%	623,100 $9.77 Million
Q4 2018 Feb 13, 2019	BUY	$14.59 - $23.84 $3.93 Million - $6.42 Million	269,306 Added 78.45%	612,596 $9.45 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $7.23 Million - $8.81 Million	343,290 New	343,290 $7.39 Million

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Strategic Global Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Global Advisors, LLC with notifications on news.